Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”

Reducing Dscam1 diversity decreases adult lifespan in a cluster-specific manner, also see S6 and S7 Figs. by Haiyang Dong (4783608)

Questionnaire description. by Cristobal Padilla-Fortunatti (21376807)

“…<div><p>Background</p><p>During the last decades, intensive care unit (ICU) mortality rates have significantly decreased but this progress has come with unintended consequences for patients and their caregivers. …”

Rising mercury consumption from blue foods in China balanced by a shift to lower-mercury choices by Wendy Wang (19812924)

Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

“…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). …”

Correlation and principal component analysis. by Jie Wei (264772)

MXene/Bi₂O₃ Nanocomposites as Supercapacitors for Portable Electronic Devices by Nanasaheb M. Shinde (8560572)

“…2D MXene nanosheets often encounter challenges such as aggregation and restacking, which can significantly decrease their performance in supercapacitor applications. …”

Determinants of institutional delivery for women who had a live birth one year before the survey, NDHS 2022. by Resham B. Khatri (10949429)

Subjects:

Trends of delivery by CS and uptake of maternity incentive among women who had at least a live birth and gave birth in HFs one year prior to the surveys. by Resham B. Khatri (10949429)

Subjects:

Determinants of childbirth in private HF among women who had a live birth one year before the survey, NDHS 2022. by Resham B. Khatri (10949429)

Subjects:

Distribution of women aged 15–49 years who had a live birth one year prior to the survey by background variables, NDHS 2022. by Resham B. Khatri (10949429)

Subjects:

Trends of uptake of delivery by CS and trends of the uptake of maternity incentives among women who had at least a live birth and gave birth in HFs one year prior to the three most... by Resham B. Khatri (10949429)

Subjects:

Determinants of uptake of maternity incentives by women who had a live birth one year prior to the survey, NDHS 2022. by Resham B. Khatri (10949429)

Subjects:

Determinant of delivery by CS for women who had a live birth in HF one year prior to the survey, NDHS 2022. by Resham B. Khatri (10949429)

Subjects:

Trends of place of delivery among women who had at least one live birth one year prior to the survey in the three most recent surveys. by Resham B. Khatri (10949429)

Subjects:

Trends of uptake of routine maternal health services among women who had a live birth one year prior to the survey in the three most recent surveys, by marginalization status. by Resham B. Khatri (10949429)

Subjects:

Model-averaged coefficients, significance, and relative importance (RI) of the predictor variables for the GLMMs to evaluate effects on: (A) overall pollinator abundance; (B) fruit... by Carmelo Gómez-Martínez (9384385)

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

“…The total number of patients who met with P-TAs was 26,842, with a 43.1% reduction from 17,105–9,737. A decrease was observed across all age groups; however, the rate was lower in the geriatric and severely injured groups. …”